Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera.
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera. Ann Hematol. 2015 Apr; 94(4):717-9.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Amino Acid Substitution
Amino Acid Substitution
Antineoplastic Agents
Antineoplastic Agents
Drug-Related Side Effects and Adverse Reactions
Drug-Related Side Effects and Adverse Reactions
Erlotinib Hydrochloride
Erlotinib Hydrochloride
Female
Female
Humans
Humans
Janus Kinase 2
Janus Kinase 2
Male
Male
Middle Aged
Middle Aged
Phenylalanine
Phenylalanine
Polycythemia Vera
Polycythemia Vera
Quinazolines
Quinazolines
Treatment Outcome
Treatment Outcome
Valine
Valine
authors with profiles
Zhizhuang Joe Zhao
Mohamad Osama Khawandanah